Introduction
============

Esophageal carcinoma (EC) constitutes one of the most common types of cancer with high mortality and incidence worldwide ([@b1-or-41-03-1627]). It is ranked fourth in mortality in China. Esophageal squamous cell carcinoma (ESCC) is the predominant histological type and represents approximately 90% of all cases in China ([@b2-or-41-03-1627]). ESCC patients always have a low survival rate since they are diagnosed at an advanced stage or even with distant metastasis ([@b3-or-41-03-1627],[@b4-or-41-03-1627]). Metastasis has become the main cause of death in these patients. Therefore, elucidating the molecular mechanism concerning its biological behaviour, such as metastasis, is essential for EC treatment.

MicroRNAs (miRNAs) are approximately 20--22 nucleotides molecules and have been reported to play an important role in tumorigenesis and development in certain cancers including ESCC ([@b5-or-41-03-1627]--[@b9-or-41-03-1627]). MircroRNA-21 (miR-21) has been revealed to be highly expressed in many solid tumors such as ESCC, oral squamous cell carcinoma (OSCC), and breast, lung and gastric cancer ([@b10-or-41-03-1627]--[@b17-or-41-03-1627]). It may therefore be considered as a new biomarker for cancer diagnosis and a new target for cancer treatment. A recent study revealed that serum miR-21 was related to the progression of ESCC ([@b12-or-41-03-1627]). Studies on miR-21 revealed that it regulated the invasion, migration and metastasis of cells (such as A549 and PC-3) ([@b9-or-41-03-1627],[@b18-or-41-03-1627]) and epithelial-mesenchymal transition (EMT), which is considered as the first step to metastasis ([@b19-or-41-03-1627]--[@b27-or-41-03-1627]). The biological behaviors of cells such as proliferation, migration and invasion have been regarded as precursors to metastasis. A previous study revealed that the expression of miR-21 was significantly altered in patients with ESCC as determined by microarray ([@b28-or-41-03-1627]). miRNAs have been demonstrated to play a regulatory role by interacting with their target genes. The results from accurate prediction software (TargetScan, miRwalk, miRanda and PITA) revealed that RAS p21 protein activator 1 (RASA1) may be the target gene of miR-21. However, the role of miR-21 and its target gene in regulating the biological behavior of ESCC has yet to be elucidated.

In the present study, cell colonies assay, wound healing and Transwell assay were used to detect the role of miR-21 and its target gene in cell proliferation, migration and invasion of ESCC. We examined the interaction between miR-21 and RASA1 using a luciferase reporter assay. The relative gene expression levels of RASA1 and miR-21 were detected by quantitative polymerase chain reaction (q-PCR). Finally, the effect of miR-21 on ESCC growth *in vivo* was examined in a nude mouse model. Generally, in the present study, we aimed to identify the role of miR-21 in the regulation of ESCC cells and to reveal some new targets for cancer treatment.

Materials and methods
=====================

### Microarray data

Gene expression profiles of GSE13937 were downloaded from the GEO repository. These data were based on the GPL8835 platform. The data of 44 patients with ESCC (including 44 samples of normal adjacent esophageal tissues and 44 samples of tumor tissues) were chosen to perform further analysis and create the heat maps with Morpheus online tool (<https://software.broadinstitute.org/morpheus/>). Then, the top 20 of differentially expressed (DE) miRNAs were screened. This study was published by Mathé *et al* ([@b28-or-41-03-1627]). Total RNA was extracted and detected by miRNA microarray chips. Version 3. R (BioConductor) (<http://www.bioconductor.org/install/>) was used for background correction and normalization of the data.

### Sample collection

All samples were collected at the Panyu Central Hospital and the Third Affiliated Hospital of Southern Medical University from February 27, 2010 to May 2, 2017. One patient was female and 19 patients were male, with a mean age of 62.4±5.8 years, and diagnosed with clinicopathological characteristics of ESCC. These samples were used only for the detection of the gene expression of miRNA and 10 patient samples among the 20 were utilized for target gene detection. All samples were stored at −80°C after collection.

### Ethics statement

This study was approved by the Ethics Committee of Panyu Central Hospital (Guangzhou, China). All patients agreed to participate provided informed consent for this study.

### Cell culture and reagents

The cell line Eca-109 (human esophageal squamous carcinoma cell) with metastatic ability and 293T cell were obtained from the State Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center (Guangzhou, China). The cell line KYSE510 (well differentiated squamous cell carcinoma cell line) was obtained from the Central Laboratory, Nanfang Hospital, Southern Medical University (Guangzhou, China). The Eca-109 and KYSE510 cells were cultured in RPMI-1640 media, supplemented with 10% fetal calf serum (FCS; Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) and were maintained under 5% CO~2~ at 37°C. The 293T cells were cultured in Dulbecco\'s modified Eagle\'s medium (DMEM; Gibco; Thermo Fisher Scientific, Inc.), supplemented with 10% FCS and 1% GlutaMAX and 1% penicillin with streptomycin.

### Animals

Ten BALB/C nude mice aged 4--6 weeks old with a male to female ratio of 1:1 weighing 20--25 g were used in the present study. These mice were obtained from Chase Reward Ltd. (Guangzhou, China) and kept under the specific pathogen-free conditions (temperature, 20--26°C; 12-h light-dark cycle; aseptic food and water). The animal experiments were approved by the Ethics Committee of Panyu Central Hospital (no. K20170002).

### Cell transfection

miR-21 mimics (overexpression), miR-21 inhibitor (downregulation) and negative control (NC including mimic NC, inhibitor NC) were purchased from Guangzhou RiboBio Co., Ltd. (Guangzhou, China). Transfections were performed on Eca-109 cells with Lipofectamine 2000 (Invitrogen; Thermo Fisher Scientific, Inc.) following the manufacturer\'s protocol. Briefly, 5×10^5^ cells were cultured in 6-well plates for 24 h prior to transfection. The miR-21 inhibitor, mimics and their NC nucleotides were added to the cell with transfection reagent to a final concentration of 50 and 100 nm/l, respectively. The cells were treated for 48 h and harvested for analysis.

### Design and construction of eukaryotic expression vector for RASA1

miRWalk (miR Walk1.0) (<http://zmf.umm.uniheidelberg.de/apps/zmf/mirwalk/micrornapredictedtarget.html>) was utilized to predict the target gene and RASA1 was predicted as the target gene of miR-21. Thus, the vector for RASA1 was constructed. The 3′ untranslated regions (3′UTR) of RASA1 mRNA were amplified using the PCR instrument (GeneAmp PCR System 2400; Applied Biosystems; Thermo Fisher Scientific, Inc.), which was bound to the mature miR-21 (MIMAT0000076). To prevent formation of a termination signal, 'taagcta' was selected as the region in a mutational expression vector template and was amplified (amplification primers are presented in [Table I](#tI-or-41-03-1627){ref-type="table"}). Then, the aforementioned template was transfected with psi-CHECK-2 luciferase plasmid and used for dual-luciferase reporter assay.

### Dual-luciferase reporter assay

The 3′UTR fragments of the RASA1 gene were amplified and then transfected and cloned into the psi-CHECK-2 luciferase miRNA expression reporter vector. The 293T cells (2×10^4^) were cultured in 24-well plates and transfected with 50 nM miR-21 mimics, 100 nM inhibitor or NC, 0.5 µg of psi-CHECK-2 luciferase reporter vector that contained the wild-type or mutant 3′UTR of RASA1 or empty plasmid. Transfections were performed using Lipofectamine 2000 (Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer\'s instructions. Forty-eight hours after transfection, the luciferase activity was assessed by the Dual-Luciferase Reporter Assay System (GloMax; Promega Corporation, Madison, WI, USA). The experiments were repeated in 3 independent experiments in duplicate.

### Cell colonies assay

Eca-109 cells (100) were cultured in 6-well plates until colonies could be observed. Then the cells were fixed by 4% of triformol and stained with Giemsa for 15 min at room temperature (Nanjing Jiancheng Taihao Biotechnology Co., Ltd., Nanjing, China). Finally, the clones were counted under a light microscope (magnification, ×100). The clone which contained \>10 cells was regarded as one colony formation, and the colony rate was calculated using the following formula: colony formation rate = (colony formation numbers/100) × 100%.

### Scratch assay

Eca-109 cells (8.0×10^5^) were cultured in 6-well plates for 24 h and confluence (\>90%) without any vacant space. Subsequently the cells were scratched using 10-µl tips with a wound midline of the culture well, and then replaced in 1% FBS DMEM. Finally, the difference in width of the wounds was measured at 0, 24 and 48 h, respectively to evaluate the migration of cells and the healing rate was calculated.

### Cell migration and invasion assay

Cell migration activities were detected using Transwell migration. After the transfected Eca-109 or KYSE510 cells were cultured for 24 h, the cells (1×10^5^) were resuspended in serum-free media and cultured in the inserts (8-µm diameter pore size; Corning Inc., Corning, NY, USA), which were placed in the 6-wells plates with 10% FBS serum media. The cells migrated from the upper surface to the lower surface of the membrane after 48-h incubation. Subsequently, the migrated cells were fixed with 100% methanol and stained with 1% toluidine. Finally, these stained cells were counted in 5 random optical fields under a light microscope (magnification, ×200). The cell invasion assay was similar to the cell migration assay except the Transwell membrane was pre-coated with 24 mg/ml Matrigel (Corning Inc.).

### Quantitative real-time PCR

Transfected Eca-109 cells and tissues were processed in TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc.) and total RNA was extracted according to the manufacturer\'s instructions. First-strand cDNA was synthesized with 1 µg total RNA per sample using the PrimeScript™ RT Synthesis system (Takara Bio, Inc., Shiga, Japan). Subsequently, the cDNA sample was amplified using QuantiTect reagents (GeneCopoeia, Inc., Rockville, MD, USA) in a final volume of 20 µl under the LightCycler 480II detector (Roche Diagnostics, Basel, Switzerland). The amplifications were performed as follows: predestination for 2 min at 50°C, denaturation for 30 sec at 95°C, followed by 40 cycles of 95°C for 5 sec, and 60°C for 34 sec. The melting curve analysis was performed to detect the specificity of amplification products. The experiments were performed in triplicate. U6 and 18S rRNA genes were used as the miRNA-21 and RASA1 endogenous reference controls, respectively. β-actin was used for the rest of the genes as an endogenous reference control. The relative gene expression level was calculated using the 2^−ΔΔCq^ method ([@b29-or-41-03-1627]). Specific sense primers are presented in [Table I](#tI-or-41-03-1627){ref-type="table"}.

### Construction of a tumor-burdened mouse model and in vivo treatment

The Eca-109 (2×10^6^) cells were subcutaneously injected in the posterior right gluteal area. When the tumor volume reached \~0.1 mm^3^, the mice were randomly assigned into 2 groups. One group received an injection with antagomir NC (10 nmol, 50 µl) and the other antagomir (10 nmol, 50 µl) every 3 days with 5 mice in each group. The tumor volume was measured before and every 3 days after treatment. The volume was calculated with the following formula: V = 1/2 (a × b^2^), in which a was the long diameter and b was the short diameter of the tumor. Twenty-one days after treatment, the mice were euthanized with CO~2~ and the tumor tissues were dissected.

### Data analysis

The data was calculated and analyzed with Excel and SPSS 13.0 packages (SPSS, Inc., Chicago, IL, USA). Data was expressed as the mean ± standard deviation (SD) of separate experiments. Statistical analysis was presented by the repeated measure, independent-samples t-test and one-way analysis of variance (ANOVA) followed by Dunnett\'s post hoc test. P\<0.05 was regarded as a significant difference.

Results
=======

### Identification DE miRNAs

A total of 627 DE miRNAs were identified. The top 20 DE miRNAs (top 20 upregulated and 20 downregulated miRNAs) was analyzed with the Morpheus online tool to form a heat map, which was screened by SNR value. The heat map revealed that miR-21 was one of the principal genes and was selected for further research ([Fig. 1](#f1-or-41-03-1627){ref-type="fig"}).

### Overexpressed miR-21 enhances the cell colony formation rate and cell healing rate

The cell colonies assay revealed that the cell colony formation rate was significantly decreased in the miR-21 inhibitor group compared with the inhibitor NC group, while the rate was significantly increased in the miR-21 mimic group compared with the mimic NC group (P\<0.05) ([Fig. 2](#f2-or-41-03-1627){ref-type="fig"}). The results of the scratch assay revealed that, the cell healing rate was significantly inhibited in the miR-21 inhibitor group compared with the inhibitor NC group after the cells were transfected for 48 h. Conversely, the healing rate was significantly enhanced in the miR-21 mimic group and the siRAS1 group compared with the mimic NC and siNC group, respectively (all P\<0.05) ([Fig. 2](#f2-or-41-03-1627){ref-type="fig"}).

### Cell migration and invasion assay

The number of migrated and invasive cells was significantly decreased in the miR-21 inhibitor group compared with the inhibitor NC group (all P\<0.05). Conversely, the cells were significantly increased in the miR-21 mimic group compared with the mimic NC group (all P\<0.05). Notably, we observed that the number of migrated and invasive Eca-109 cells was also significantly increased in the siRASA1 group compared with the siNC group (all P\<0.05). Similar results were also obtained with the KYSE510 cells ([Figs. 3](#f3-or-41-03-1627){ref-type="fig"} and [4](#f4-or-41-03-1627){ref-type="fig"}).

### Construction of a vector for RASA1

The sequence of RASA1 3′UTR which was combined to miR-21 (mature sequence: UAGCUUAUCAGACUGAUGUUGA) was amplified and detected at 1043 bp using electrophoresis. The vector with mutated or wild-type RASA1 was constructed and used for the luciferase reporter assay ([Fig. 5A-C](#f5-or-41-03-1627){ref-type="fig"}).

### Dual-luciferase reporter assay

The result of the dual-luciferase reporter assay revealed that the luciferase activity in the miR-21 group transfected with the RASA1 vector was significantly inhibited compared with the NC and the blank group (P\<0.05) ([Fig. 5D](#f5-or-41-03-1627){ref-type="fig"}), while the activity in the miR-21 group transfected with the RASA1 mutated vector was not significantly altered compared with the NC and the blank group (P\>0.05) ([Fig. 5E](#f5-or-41-03-1627){ref-type="fig"}).

### q-PCR results

It predicted that RASA1 may be the target gene of miR-21 by miRWalk. Their relative expression by PCR revealed that miR-21 was significantly increased and RASA1 was decreased in the tumor tissues compared to the normal adjacent tissues in patients with ESCC ([Fig. 1B](#f1-or-41-03-1627){ref-type="fig"}). The gene level of RASA1 was significantly increased when the Eca-109 cells were transfected with the miR-21 inhibitor compared with the inhibitor NC (P\<0.05). Conversely, the expression was significantly reduced in the miR-21 mimic group when compared with the mimic NC group (P\<0.05). The expression of miR-21 was significantly increased in the group of cells which were transfected with siRASA1 when compared with the siNC group (P\<0.05) ([Fig. 5F](#f5-or-41-03-1627){ref-type="fig"}). The relative gene expression of Snail and vimentin was significantly increased by upregulated miR-21 or downregulated RASA1 ([Fig. 6](#f6-or-41-03-1627){ref-type="fig"}).

### The effect of miR-21 in tumor xenografts

Nude mice bearing tumors were established to evaluate the effects of miR-21 inhibitor (antagomir) on esophageal carcinoma growth *in vivo*. Compared to the NC group, application of antagomir significantly inhibited the growth of the tumor 6 days after treatment (P\<0.05). The mice volume in the 2 groups was not significantly different before treatment (P\>0.05) ([Fig. 7](#f7-or-41-03-1627){ref-type="fig"}). No diarrhea or body weight loss was observed in any of the animals.

Discussion
==========

Recent studies have revealed that miRNAs play an important role in tumorigenesis and progression. They are involved in multiple biological processes, including tumor invasion, migration, proliferation and metastasis. miR-21 has been reported to be overexpressed in certain cancers including ESCC patients and may become a new biomarker for tumor diagnosis. A study by Winther *et al* ([@b30-or-41-03-1627]) revealed that miR-21 could be identified as an independent prognostic biomarker for disease-specific survival (DSS) in esophagogastric adenocarcinomas (EAC) patients. Lv *et al* ([@b31-or-41-03-1627]) revealed that miR-21 was overexpressed in Kazak or Uighur EC patients and was an independent factor for prognosis. Considering its pivotal role for diagnosis, researchers drew attention to the role of miR-21 in tumor processes such as invasion, migration and metastasis. Shen *et al* ([@b9-or-41-03-1627]) found that solasodine could downregulate the expression of miR-21 and increase its target gene RECK to inhibit the invasion of A549 cells. Yang *et al* ([@b18-or-41-03-1627]) studied the biological behaviors of miR-21 in prostate cancer cell lines PC-3 and found that miR-21 could promote cell proliferation and invasion by overexpression of miR-21 to target PTEN. As aforementioned, miR-21 is expected to become a new target in cancer treatment ([@b4-or-41-03-1627],[@b32-or-41-03-1627],[@b33-or-41-03-1627]--[@b35-or-41-03-1627]). However, the role that miR-21 plays in the biological behavior of ESCC has yet to be elucidated.

In the present study, we concentrated on the role of miR-21 and its target gene in the biological behavior of ESCC cell lines. From the data of microarray analysis, miR-21 was found to be one of the 20 top DE miRNAs (upregulated) in patients with ESCC. Our results also revealed that the relative expression of miR-21 was significantly increased in tumor tissues compared to normal adjacent tissues. Furthermore, the results revealed that RASA1 may be a target gene of miR-21 and that miR-21 and its target gene may play an important role in regulating ESCC. Thus, a functional experiment of miR-21 and RASA1 was performed on ESCC cell lines. Notably, we observed that overexpressed miR-21 could significantly enhance the healing rate and increase the number of invasive and migrated cells as well as the cell colony formation rate. Conversely, downregulation of the expression of miR-21 could significantly inhibit the healing rate and decrease the number of invasive and migrated cells as well as the cell colony formation rate. Futhermore, downregulated RASA1 (siRASA1), significantly increased the number of invasive and migrated cells. These results indicated that miR-21 and its target gene RASA1 regulated cell invasion, migration and proliferation of ESCC cells.

It has been reported that miRNAs negatively regulate their target gene via binding to the 3′UTR of target mRNAs, which causes mRNA degradation suppressing translation ([@b31-or-41-03-1627]). In the present study, we observed that overexpression of miR-21 significantly decreased the expression of RASA1. Conversely, downregulated miR-21 significantly increased the RASA1 gene expression. These results revealed that miR-21 negatively regulated RASA1. In order to further elucidate the relationship between RASA1 and miR-21, we constructed an mRNA vector of RASA1 combined to mature miR-21 and performed a luciferase reporter assay. The assay revealed that RASA1 was combined with miR-21. With the PCR results, the relative gene expression of Snail and vimentin was significantly increased by upregulated miR-21 or downregulated RASA1. These results indicated that miR-21 directly targeted RASA1, and that the regulatory role may be via Snail and vimentin. RASA1 was firstly discovered as a RAS guanosine triphosphate enzyme-activated protein, which inactivated RAS to inhibit the RAS downstream pathway, thereby resulting in the proliferation, migration, invasion and metastasis of cancer cells. Snail is a pivotal gene which is related to EMT. Thus, we hypothesized that miR-21 regulated migration and invasion by directly targeting RASA1 which may be via regulation of Snail. However, the precise mechanism in the downstream pathway requires further research.

In order to investigate the effect of miR-21 *in vivo*, we set up a nude mouse tumor-bearing model. We observed that application of miR-21 inhibitor significantly inhibited the growth of the tumor compared to the NC group at days 3 and 6 after treatment, respectively. This indicated that anti-miR-21 had an antitumor effect and may be considered as a promising target for ESCC therapy.

In conclusion, miR-21 regulated cell proliferation, migration, invasion and tumor growth of ESCC by directly targeting RASA1, possibly via regulation of Snail. miR-21 and RASA1 may be considered as possible targets for ESCC therapy.
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![Heat map of the top 20 DE miRNAs screened using Morpheus online tool and the relative expression in tissues. (A) The results revealed that miR-21 was one of the top 20 DE miRNAs which was upregulated in patients with ESCC. The GSM identified with No. 1 represent the adjacent esophageal tissue, and No. 2 represent the tumor tissue. (B) The relative expression of miR-21 and RASA1 in the tumor tissues compared to the normal adjacent tissues in the patients with ESCC. A total of twenty patients with ESCC were enrolled in this study. The results revealed that the expression of miR-21 was significantly increased in the tumor tissues while RASA1 was significantly downregulated (\*P\<0.05). DE, differentially expressed; miR-21, microRNA-21; ESCC, esophageal squamous cell carcinoma.](OR-41-03-1627-g00){#f1-or-41-03-1627}

![Effect of miR-21 on the colony formation rate and healing rate of ESCC *in vitro*. (A) Cells from a wound healing assay viewed under a microscope (magnification, ×100). (B) Cells from a colony formation assay viewed under a microscope. (C) The cell healing rate of the miR-21 inhibitor group was significantly inhibited compared with the inhibitor NC group after the cells were transfected for 48 h, while the healing rate was significantly enhanced in the miR-21 mimic and siRASA1 group compared with the mimic NC and the siNC group, respectively. 1 represents for 24 h, 2 represents for 48 h. (D) The cell colony formation rate was significantly decreased in the miR-21 inhibitor group compared with the inhibitor NC group, while the rate was significantly increased in the miR-21 mimic group compared with the mimic NC group (\*P\<0.05). miR-21, microRNA-21; ESCC, esophageal squamous cell carcinoma; RASA1, RAS p21 protein activator 1.](OR-41-03-1627-g01){#f2-or-41-03-1627}

![Transwell assay of miR-21 and RASA1 on ESCC cell line Eca-109 *in vitro*. (A and C) Cells from a migration assay viewed under a microscope (magnification in A was ×400, magnification in C was ×200). (B and D) Cells from an invasion assay viewed under a microscope (magnification, ×200). (E) The number of migrated cells were significantly decreased in the miR-21 inhibitor group compared with the inhibitor NC group, while they were significantly increased in the miR-21 mimic group compared with the mimic NC group, and the siRASA1 group compared with the siNC group. (F) The number of invasive cells was significantly decreased in the miR-21 inhibitor group compared with the inhibitor NC group, while they were significantly increased in the miR-21 mimic group compared with the mimic NC group, and the siRASA1 group compared with the siNC group (\*P\<0.05). miR-21, microRNA-21; ESCC, esophageal squamous cell carcinoma; RASA1, RAS p21 protein activator 1.](OR-41-03-1627-g02){#f3-or-41-03-1627}

![Transwell assay of miR-21 on ESCC cell line KYSE510 *in vitro*. (A) Cells from a migration assay viewed under a microscope (magnification, ×200). (B) Cells from an invasion assay viewed under a microscope (magnification, ×200). (C) Group 1, migrated KYSE510 cells; group 2, invaded KYSE510 cells. The number of migrated cells were significantly decreased in the miR-21 inhibitor group compared with the inhibitor NC group, while they were significantly increased in the miR-21 mimic group compared with the mimic NC group. In addition, the number of invasive cells was significantly decreased in the miR-21 inhibitor group compared with the inhibitor NC group, while they were significantly increased in the miR-21 mimic group compared with the mimic NC group (\*P\<0.05). miR-21, microRNA-21; ESCC, esophageal squamous cell carcinoma.](OR-41-03-1627-g03){#f4-or-41-03-1627}

![Interaction between miR-21 and RASA1 is detected by luciferase assay and q-PCR. (A) The construction of the vector. (B) The mechanism of the luciferase assay. (C) The combined site of RASA1 and miR-21. (D) The luciferase activity in the miR-21 group transfected with RASA1 vector was significantly inhibited compared with the NC and blank group. (E) The activity in the miR-21 group transfected with RASA1 mutated vector was not significantly altered compared with the NC and the blank group. (F) The expression of RASA1 was significantly increased in the Eca-109 cell transfected with the miR-21 inhibitor compared with the inhibitor NC, and decreased in the miR-21 mimic group when compared with the mimic NC group. In addition, the expression of miR-21 was significantly increased in the group of cells which were transfected with siRASA1 when compared with the siNC group (\*P\<0.05). miR-21, microRNA-21; RASA1, RAS p21 protein activator 1; q-PCR, quantitative polymerase chain reaction.](OR-41-03-1627-g04){#f5-or-41-03-1627}

![The relative gene expression. Group 1, the relative gene expression of signaling molecules in ESCC cell line Eca-109, with upregulated miR-21 (mimic). Group 2, the relative gene expression of signaling molecules in Eca-109 cells with downregulated of RASA1 (siRASA1). The relative gene expression of Snail and vimentin were significantly increased by upregulated miR-21 or downregulated RASA1 (\*P\<0.05). miR-21, microRNA-21; ESCC, esophageal squamous cell carcinoma; RASA1, RAS p21 protein activator 1.](OR-41-03-1627-g05){#f6-or-41-03-1627}

![The effect of miR-21 on tumor xenografts. (A) Nude mice bearing tumors were established to evaluate the effects of miR-21 inhibitor (antagomir) on esophageal carcinoma growth *in vivo* (mm^3^). Application of miR-21 antagomir significantly inhibited the growth of the tumors compared with the NC group, 3 and 6 days after treatment, respectively (P\<0.05). The tumor volume was not significant different before treatment (P\>0.05). (B) The tumor masses excised from the nude mice. miR-21, microRNA-21; ESCC, esophageal squamous cell carcinoma; RASA1, RAS p21 protein activator 1.](OR-41-03-1627-g06){#f7-or-41-03-1627}

###### 

The primer sequence of the genes.

  Gene              Primer (5′-3′)
  ----------------- -------------------------------------------------------------------
  RASA13′           UTR-F: ccgctcgagCAGCCTTCGCCCCAGTGTTCTG
  RASA13′           UTR-R: ataagaatgcggccgcTAATCAATTATGCAAGATATCCC
  mutation RASA1:   
  RASA13′           UTR-mF: GTGAATAACTATGCCAGCAACCTTGATTCGATTCTGTGCAGGATATTTGCACTATTT
  RASA13′           UTR-mR: ataagaatgcggccgcTAATCAATTATGCAAGATATCCC
  RASA1-F:          GAACTTGGGAATGTACCTGAAC
  RASA1-R:          TGTGCACCACGCTCATTAC
  miR-21-F:         ACACTCCAGCTGGGTAGCTTATCAGACTGATG
  miR-21-RT:        CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGTCAACATC
  miRNA-R:          CTCAACTGGTGTCGTGGA
  U6-F:             CTCGCTTCGGCAGCACA
  U6-R:             AACGCTTCACGAATTTGCGT
  K-ras-F:          GAGGCCTGCTGAAAATGAC
  K-ras-R:          GCTGTGTCGAGAATATCCAA
  AKT-F:            ATCGCTTCTTTGCCGGTATC
  AKT-R:            CTTGGTCAGGTGGTGTGATG
  PI3K-F:           AGGGAGCGAGTGCCTTTTAT
  PI3K-R:           AAGCCCTGCAGTCAACATCA
  E-caherin-F:      GTACTCAAAGCCCAGAATCC
  E-caherin-R:      CCCTCAACTAACCCCCTTTA
  Vimentin-F:       CGCCAGATGCGTGAAATGG
  Vimentin-R:       ACCAGAGGGAGTGAATCCAGA
  Snail-F:          TGGTTGCTTCAAGGACACAT
  Snail-R:          GTTGCAGTGAGGGCAAGAA
  18s rRNA-F:       CCTGGATACCGCAGCTAGGA
  18s rRNA-R:       GCGGCGCAATACGAATGCCCC
  β-actin-F:        ACTCTTCCAGCCTTCCTTCC
  β-actin-R:        GTACTTGCGCTCAGGAGGAG

F, forward; R, reverse; mF, forward primer of the mutant RASA1; mR, reverse primer of mutant RASA1; RT, reverse transcription primer of miR-21.

[^1]: Contributed equally
